Division of Clinical Pharmacology and Toxicology, Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland.
ReseaChem GmbH, Burgdorf, Switzerland.
Neuropharmacology. 2018 May 15;134(Pt A):141-148. doi: 10.1016/j.neuropharm.2017.07.012. Epub 2017 Jul 15.
4-Thio-substituted phenethylamines (2C-T drugs) are potent psychedelics with poorly defined pharmacological properties. Because of their psychedelic effects, 2C-T drugs are sometimes sold as new psychoactive substances (NPSs). The aim of the present study was to characterize the monoamine receptor and transporter interaction profiles of a series of 2C-T drugs.
We determined the binding affinities of 2C-T drugs at monoamine receptors and transporters in human cells that were transfected with the respective receptors or transporters. We also investigated the functional activation of serotonergic 5-hydroxytryptamine 2A (5-HT) and 5-HT receptors, activation of human trace amine-associated receptor 1 (TAAR), and inhibition of monoamine uptake transporters.
2C-T drugs had high affinity for 5-HT and 5-HT receptors (1-54 nM and 40-350 nM, respectively). With activation potencies of 1-53 nM and 44-370 nM, the drugs were potent 5-HT receptor and 5-HT receptor, respectively, partial agonists. An exception to this were the benzylthiophenethylamines, which did not potently activate the 5-HT receptor (EC > 3000 nM). Furthermore, the compounds bound to serotonergic 5-HT and adrenergic receptors. The compounds had high affinity for the rat TAAR (5-68 nM) and interacted with the mouse but not human TAAR. The 2C-T drugs did not potently interact with monoamine transporters (K > 4000 nM).
The receptor binding profile of 2C-T drugs predicts psychedelic effects that are mediated by potent 5-HT receptor interactions. This article is part of the Special Issue entitled 'Designer Drugs and Legal Highs.'
4-硫代取代苯乙胺(2C-T 药物)是具有定义不明确的药理学特性的强效迷幻剂。由于其致幻作用,2C-T 药物有时被作为新型精神活性物质(NPS)出售。本研究旨在描述一系列 2C-T 药物对单胺受体和转运体相互作用的特性。
我们测定了 2C-T 药物在转染相应受体或转运体的人细胞中单胺受体和转运体的结合亲和力。我们还研究了 5-羟色胺 2A(5-HT)和 5-HT 受体的血清素能功能激活、人痕迹胺相关受体 1(TAAR)的激活以及单胺摄取转运体的抑制。
2C-T 药物对 5-HT 和 5-HT 受体具有高亲和力(分别为 1-54 nM 和 40-350 nM)。这些药物作为 5-HT 受体和 5-HT 受体的部分激动剂,具有 1-53 nM 和 44-370 nM 的激活效力。除了苄基噻吩乙胺之外,它们没有强烈地激活 5-HT 受体(EC > 3000 nM)。此外,这些化合物与血清素能 5-HT 和肾上腺素能受体结合。这些化合物对大鼠 TAAR 具有高亲和力(5-68 nM),并与小鼠而非人 TAAR 相互作用。2C-T 药物与单胺转运体没有强烈的相互作用(K > 4000 nM)。
2C-T 药物的受体结合谱预测了通过强烈的 5-HT 受体相互作用介导的致幻作用。本文是特刊“设计药物和合法兴奋药”的一部分。